Bone Tumor Ablation Devices Market Expected to Expand at a Steady 2021-2028 | Medtronic Plc., Merit Medical Systems Inc., MedWaves Inc., AngioDynamics Inc.

Another factual information on the "𝐁𝐨𝐧𝐞 𝐓𝐮𝐦𝐨𝐫 𝐀𝐛𝐥𝐚𝐭𝐢𝐨𝐧 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭" has as of late added by CMI to its storehouse. This global research report offers an inside and out examination of various perspectives, for example, global market patterns, pieces of the overall industry, drivers, restrictions, opportunities. It gives an investigative view to settle on further choices in organizations. It covers comprehensive instructive information of various key players working over the globe.

𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰

When the cells within a bone are divided without control, bone tumor is developed which forms a lump or mass of abnormal tissue. This bone tumors are mostly benign i.e., not cancerous and generally not life-threatening and do not spread in other parts of the body in most cases. On basis of the tumor type, there are wide range of treatments from clinical observation to surgery for the tumor removal. The health of bone significantly worsens with age which leads to more number of accidents and consequent fractures. In 2014, the National Osteoporosis Foundation had released statistics which revealed that around 43.4 million adults had low bone mass and another 10 million adults had osteoporosis, signifying over 1/4th adult population in U.S. was affected by bone disorders in 2013.

𝐋𝐈𝐌𝐈𝐓𝐄𝐃 𝐓𝐈𝐌𝐄 𝐎𝐅𝐅𝐄𝐑 – 𝐇𝐮𝐫𝐫𝐲 𝐔𝐩 !!!!

𝐁𝐮𝐲-𝐍𝐨𝐰 𝐚𝐧𝐝 𝐆𝐞𝐭 𝐔𝐏𝐓𝐎 𝟖𝟎% 𝐎𝐅𝐅 @ https://www.coherentmarketinsights.com/insight/buy-now/4319

𝐈𝐦𝐩𝐚𝐜𝐭 𝐨𝐟 𝐂𝐨𝐫𝐨𝐧𝐚𝐯𝐢𝐫𝐮𝐬 (𝐂𝐨𝐯𝐢𝐝-𝟏𝟗) 𝐏𝐚𝐧𝐝𝐞𝐦𝐢𝐜

In majority of bone tumor patients, bone tumor ablation surgery is required for curing and managing the painful bone metastatic. The treatment techniques such as chemo-therapy, immune-therapy, and surgery of cancer patients were often postponed or cancelled due to COVID-19 pandemic. During this period, the bone tumor ablation surgery has become a preferable option for treatment due to its minimal invasiveness, time, and its cost-effectiveness. In 2014, the NCBI revealed that the bone tumor ablation of painful metastatic bone disorder is considered as safe and is observed to minimize the pain and has shown improved life quality for cancer patients. During the pandemic, the provision of care services to the bone cancer patients was challenging considering the risk of death of cancer patients against the death of patients from SARS-CoV-2 along with the higher chances of COVID-19 in immune comprised hosts.

𝐓𝐡𝐞 𝐛𝐨𝐧𝐞 𝐭𝐮𝐦𝐨𝐫 𝐚𝐛𝐥𝐚𝐭𝐢𝐨𝐧 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐝𝐞𝐥𝐢𝐯𝐞𝐫 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟏𝟎.𝟐% 𝐨𝐯𝐞𝐫 𝐭𝐡𝐞 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐩𝐞𝐫𝐢𝐨𝐝 (𝟐𝟎𝟐𝟎-𝟐𝟎𝟐𝟕) 𝐚𝐧𝐝 𝐢𝐬 𝐞𝐬𝐭𝐢𝐦𝐚𝐭𝐞𝐝 𝐭𝐨 𝐛𝐞 𝐰𝐨𝐫𝐭𝐡 𝐚𝐭 𝐔𝐒$ 𝟓𝟔.𝟐 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟎.

For treatment of bone tumors, there are various ablation techniques available which provide several benefits such as these techniques being least invasive, enable tumor destruction targets, and low complication rates. The most commonly used techniques are Radio-frequency Thermal Ablation (RFTA) and Cryosurgery.

𝐌𝐚𝐣𝐨𝐫 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: Medtronic Plc., Merit Medical Systems Inc., MedWaves Inc., AngioDynamics Inc., Olympus Corporation, Varian Medical Systems, Inc., Mermaid Medical A/S, RF Medical Co., Ltd., and Misomix Inc.

𝐃𝐫𝐢𝐯𝐞𝐫𝐬

Rising launches of bone tumor ablation devices products is expected to stimulate growth of the global bone tumor ablation devices market.

Involvement of major players of the market in development and launch of novel bone tumor ablation devices is expected to significantly drive growth of the global bone tumor ablation devices market and generate a conductive environment for this market during the forecast period. In January 2016, Medtronic Plc., launched OsteoCool RF ablation system for treatment of spine metastases which provides dual-probe and simultaneous capabilities in treatment of painful bone tumors. In 2017, Medtronic Plc., launched OsteoCool RF ablation system for indication bone metastases in Canada. Moreover, in 2015, DFINE Inc., launched a Long SpineStar ablation instrument for metastatic spine tumor’s palliative treatment. This SpineStar ablation instrument is the only steerable and navigational radio-frequency device available in the market.

Moreover, rising cases of bone cancer are expected to create promising opportunities for growth of the bone tumor ablation devices market. In 2016, the American Cancer Society (ACS) had reported about 3,300 new cases of bone cancer along with 1,490 deaths in the U.S. Furthermore, the source continued that around 40% of primary bone cancers were chondrosarcomas in adults.

𝐆𝐞𝐭 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 𝐎𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐂𝐨𝐯𝐢𝐝𝟏𝟗 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 @ https://www.coherentmarketinsights.com/insight/request-pdf/4319

𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧

𝐎𝐧 𝐭𝐡𝐞 𝐛𝐚𝐬𝐢𝐬 𝐨𝐟 𝐈𝐧𝐝𝐢𝐜𝐚𝐭𝐢𝐨𝐧: Ewing’s Sarcoma, Osteosarcoma, Metastatic Bone Cancer, Chondrosarcoma, and Others.

𝐎𝐧 𝐭𝐡𝐞 𝐛𝐚𝐬𝐢𝐬 𝐨𝐟 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲: Cryoablation, Radiofrequency Ablation, Microwave Ablation, and Others.

𝐎𝐧 𝐭𝐡𝐞 𝐛𝐚𝐬𝐢𝐬 𝐨𝐟 𝐄𝐧𝐝 𝐔𝐬𝐞𝐫: Specialty Clinics, Hospitals, and Ambulatory Surgical Centers.

𝐑𝐞𝐬𝐭𝐫𝐚𝐢𝐧𝐭𝐬

Major factors such as lack of awareness regarding the novel technologies and therapy advancements among the patients and healthcare professionals about the bone tumor ablation surgery, is expected to hamper growth of the bone tumor ablation devices market. The awareness of such novel technologies is very low among the rural areas of emerging economies such as Asia Pacific and Africa, which is expected to a major restraining factor in adoption of bone tumor ablation devices in these regions, hence limiting the market growth. Furthermore, scarcity of skilled professionals for surgery in these regions, minimal lifespan of bone tumor ablation devices, and the higher time for approval for the launch of product are all expected to be the major hindering factors in growth of the bone tumor ablation market over the forecast period.

𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬

Over the forecast period, the North American region is expected to be the most lucrative region for the bone tumor ablation devices market. Increase in prevalence of osteosarcoma is expected to propel the market growth in this region. As per the report from American Cancer Society, every year around 800-900 new cases of osteosarcoma are diagnosed in the U.S. with 50% of these cases occurring in teenagers and children, which is further expected to exhibit growth of the bone tumor ablation devices market in North American region.

Asia Pacific is expected to witness growth of the bone tumor ablation devices market due to the accelerated adoption of minimally invasive treatment therapies. The current conferences taking place in Asia Pacific region about the use of ablation technology are expected to create awareness about ablation technology among healthcare providers. In 2019, the Asian Conference of Tumor Ablation (ACTA) was held in Chang Gung Memorial Hospital of Taiwan on ablation technology. This conference mainly focused on technical tips and principles related to microwave ablation (MW), radio-frequency ablation (RFA), irreversible electroporation (IRE), cryoablation, and several guiding techniques with inclusion of imaging fusion were also introduced in this event.

𝐁𝐮𝐲 𝐍𝐨𝐰 𝐰𝐢𝐭𝐡 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐟𝐨𝐫 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 : https://www.coherentmarketinsights.com/insight/buy-now/4319

As per specific needs, customizations of the given market data is also available. Talk to our research consultant to design an exclusive report as per your research needs like Regional and country-level analysis of the market by end-use, detailed analysis, and profiles of additional market players.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com

𝐀𝐛𝐨𝐮𝐭 𝐂𝐨𝐡𝐞𝐫𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬:

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

This release was published on openPR.